Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 3Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 7Sarcoma 6Lymphoma 6Testicular Neoplasms 5Testicular Germ Cell Tumor 5Ovarian Neoplasms 5Osteosarcoma 5Lymphoma, Follicular 5Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Anaplastic 4Burkitt Lymphoma 4Recurrence 3Lymphoma, Large-Cell, Immunoblastic 3Immunoblastic Lymphadenopathy 3Central Nervous System Neoplasms 3Waldenstrom Macroglobulinemia 2Teratoma 2Solitary Fibrous Tumors 2Small Cell Lung Carcinoma 2Sarcoma, Clear Cell 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Lymphoma, Extranodal NK-T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hemangiosarcoma 2Hemangioendothelioma, Epithelioid 2Dendritic Cell Sarcoma, Interdigitating 2

Interventions

pembrolizumab 37Carboplatin 26Radiotherapy 23Cisplatin 19Paclitaxel 18Erlotinib Hydrochloride 18Docetaxel 15Gemcitabine 14Pemetrexed 13Etoposide 12osimertinib 11Nivolumab 11durvalumab 9atezolizumab 9Radiosurgery 8Magnetic Resonance Spectroscopy 8Cetuximab 7Specimen Handling 6Cyclophosphamide 6130-nm albumin-bound paclitaxel 6Taxes 5Immunoglobulin G 5Gefitinib 5Biopsy 5Bevacizumab 5fludarabine 4Radiation 4Ipilimumab 4Disulfides 4Albumin-Bound Paclitaxel 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Lung Neoplasms × Ifosfamide × Clear all
NCT00004186 2013-04-12

Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer

University of Alabama at Birmingham

Phase 1/2 Completed
55 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡